• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Sofosbuvir and simeprevir-based schemes for the management of hepatitis C]
2015     NIHR Horizon Scanning Centre (NIHR HSC) Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Nonoperative correction of pectus carinatum with orthotic bracing]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Raltegravir for the treatment of human immunodeficiency virus infection]
2015     NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Radiofrequency ablation for Barrett´s esophagus with high-grade dysplasia or intramucosal cancer: a systematic review]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Ombitasvir, paritaprevir and ritonavir regimens in hepatitis C patients]
2015     NIHR Health Technology Assessment programme Clinical effectiveness of elemental nutrition for the maintenance of remission in Crohn's disease: a systematic review and meta-analysis
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficiency, effectiveness and safety of mechanical ventricular assistance with HeartWare® device in terminal heart failure]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Ceritinib for the treatment of ALK-positive metastatic non-small cell lung cancer]
2015     NIHR Health Technology Assessment programme Effectiveness and economic evaluation of self-help educational materials for the prevention of smoking relapse: randomised controlled trial
2015     NIHR Health Technology Assessment programme The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Epratuzumab for systemic lupus erythematosus
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Vitamin D screening in adults]
2015     NIHR Health Technology Assessment programme Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Cabazitaxel, abiraterone and enzalutamide in metastatic castration-resistant prostate cancer not responding to docetaxel]
2015     NIHR Health Technology Assessment programme A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Tecar therapy for the management of osteoarticular lesions]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Levonorgestrel (Jaydess®)
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging for focal liver lesion assessment]
2015     NIHR Health Technology Assessment programme The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Avanafil (Spedra®)
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) in osteoarthritis]
2015     NIHR Health Technology Assessment programme Interventions to treat premature ejaculation: a systematic review short report
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Regorafenib (Stivarga®)
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in cognitive deficit secondary to stroke]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficacy of intraoperative radiation therapy]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Peginterferon beta-1a (Plegridy®)
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Omalizumab for the management of asthma]
2015     NIHR Health Technology Assessment programme A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Assisted reproduction]
2015     NIHR Health Services and Delivery Research programme Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of the ALCAT test in food intolerance]
2015     NIHR Health Technology Assessment programme Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Development framework for social services practice guidelines]
2015     NIHR Health Services and Delivery Research programme Care and communication between health professionals and patients affected by severe or chronic illness in community care settings: a qualitative study of care at the end of life
2015     NIHR Health Technology Assessment programme Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Intravascular ultrasound guided coronary stent insertion
2015     NIHR Health Technology Assessment programme High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis
2015     NIHR Health Services and Delivery Research programme Evaluation of a continuous monitoring and feedback initiative to improve quality of anaesthetic care: a mixed-methods quasi-experimental study
2015     NIHR Public Health Research (PHR) programme Sexual health promotion for young people delivered via digital media: a scoping review
2015     NIHR Health Technology Assessment programme Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and Nobreath
2015     Medical Services Advisory Committee (MSAC) Bronchial thermoplasty for the treatment of severe persistent asthma
2015     NIHR Public Health Research (PHR) programme A cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of a school-based cognitive behavioural therapy programme (FRIENDS) in the reduction of anxiety and improvement in mood in children aged 9/10 years
2015     NIHR Horizon Scanning Centre (NIHR HSC) XEN Gel Stent for glaucoma treatment
2015     Medical Services Advisory Committee (MSAC) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2015     NIHR Horizon Scanning Centre (NIHR HSC) Permaseal for soft tissue access and closure during procedures
2015     NIHR Health Technology Assessment programme Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation
2015     Medical Services Advisory Committee (MSAC) Active middle ear implant for sensorineural hearing loss
2015     NIHR Horizon Scanning Centre (NIHR HSC) ENROUTE transcarotid neuroprotection and stent systems
2015     Medical Services Advisory Committee (MSAC) Transcatheter aortic valve implantation via transfemoral or transapical delivery
2015     NIHR Horizon Scanning Centre (NIHR HSC) AventaMed device for tympanostomy tube placement
2015     NIHR Health Technology Assessment programme Effectiveness and acceptability of parental financial incentives and quasi-mandatory schemes for increasing uptake of vaccinations in preschool children: systematic review, qualitative study and discrete choice experiment
2015     Medical Services Advisory Committee (MSAC) Intravascular ultrasound (IVUS) guided coronary stent insertion
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ostom-I Alert Sensor for use with ostomy bags
2015     Medical Services Advisory Committee (MSAC) An assessment of nucleic acid amplification testing for active mycobacterial infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Hand-held Fourier transform infrared (FTIR) spectroscopy to diagnose and monitor COPD
2015     NIHR Health Technology Assessment programme Idelalisib for relapsed chronic lymphocytic leukaemia [ID764]
2015     Medical Services Advisory Committee (MSAC) F-18 Fluorodeoxyglucose positron emission tomography (FDG PET) for the diagnosis of Alzheimer's disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Arsenal ResQFoam™ for non-compressible abdominal haemorrhage
2015     Belgian Health Care Knowledge Centre (KCE) Towards a guided and phased introduction of high-risk medical devices in Belgium
2015     NIHR Horizon Scanning Centre (NIHR HSC) XStat® Hemostatic Device for non-compressible junctional haemorrhage
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation
2015     Belgian Health Care Knowledge Centre (KCE) Implementation of hospital at home: orientations for Belgium
2015     University of York Enhancing access in primary care settings
2015     Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: OHTAC recommendation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nitric Oxide generating gel dressing for diabetic foot ulcers
2015     Institute for Clinical and Economic Review (ICER) Bariatric surgery
2015     Institute for Clinical Evaluative Sciences (ICES) Brain disorders in Ontario: prevalence, incidence and costs from health administrative data
2015     Health Quality Ontario (HQO) Paclitaxel drug-eluting stents in peripheral arterial disease: a health technology assessment
2015     NIHR Horizon Scanning Centre (NIHR HSC) Freedom Spinal Cord Stimulator System for chronic back and leg pain
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin degludec/liraglutide (Xultophy®)
2015     Technology Assessment at SickKids (TASK) Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective
2015     NIHR Horizon Scanning Centre (NIHR HSC) Inreda artificial pancreas device for Type 1 diabetes
2015     NIHR Public Health Research (PHR) programme Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fosfomycin (Fomicyt®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rapid Rhythm ECG for atrial fibrillation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Travoprost (Travatan®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Noctura 400 Sleep Mask for diabetic retinopathy
2015     NIHR Health Technology Assessment programme Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis
2015     NIHR Health Technology Assessment programme Apremilast for psoriatic arthritis [ID682]
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Midodrine hydrochloride (Bramox®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) OnPulse™ nerve stimulation technology for urinary and faecal incontinence
2015     The Swedish Council on Health Technology Assessment (SBU) [Non-invasive prenatal test for Down's syndrome]
2015     NIHR Health Technology Assessment programme Apremilast for treating moderate to severe plaque psoriasis [ID679]
2015     Adelaide Health Technology Assessment (AHTA) Life saving drugs programme review: technical assessment
2015     NIHR Horizon Scanning Centre (NIHR HSC) Fall-Safe Assist device for the prevention and detection of falls
2015     The Swedish Council on Health Technology Assessment (SBU) [Interventions to prevent misuse of alcohol, drugs and gambling in youth]
2015     NIHR Health Technology Assessment programme Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation [ID624]
2015     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Bioquell airborne disinfection system]
2015     NIHR Horizon Scanning Centre (NIHR HSC) Reza Band® for laryngopharyngeal reflux
2015     The Swedish Council on Health Technology Assessment (SBU) [Instruments for suicide risk assessment]
2015     NIHR Health Technology Assessment programme Ledipasvir-sofosbuvir for treating chronic hepatitis C [ID742]
2015     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Pre-hospital ECMO for refractory cardiac arrest]
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sonata™ System for the removal of uterine fibroids
2015     Medical Services Advisory Committee (MSAC) Ranibizumab for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)
2015     NIHR Health Technology Assessment programme Olaparib for maintenance treatment of BRCA 1 or 2 mutated, relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer in people whose relapsed disease has responded to platinum-based chemotherapy [735]